Plasma Treatment Limits Human Melanoma Spheroid Growth and Metastasis Independent of the Ambient Gas Composition
Melanoma skin cancer is still a deadly disease despite recent advances in therapy. Previous studies have suggested medical plasma technology as a promising modality for melanoma treatment. However, the efficacy of plasmas operated under different ambient air conditions and the comparison of direct a...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/9/2570 |
_version_ | 1797554116150427648 |
---|---|
author | Sybille Hasse Tita Meder Eric Freund Thomas von Woedtke Sander Bekeschus |
author_facet | Sybille Hasse Tita Meder Eric Freund Thomas von Woedtke Sander Bekeschus |
author_sort | Sybille Hasse |
collection | DOAJ |
description | Melanoma skin cancer is still a deadly disease despite recent advances in therapy. Previous studies have suggested medical plasma technology as a promising modality for melanoma treatment. However, the efficacy of plasmas operated under different ambient air conditions and the comparison of direct and indirect plasma treatments are mostly unexplored for this tumor entity. Moreover, exactly how plasma treatment affects melanoma metastasis has still not been explained. Using 3D tumor spheroid models and high-content imaging technology, we addressed these questions by utilizing one metastatic and one non-metastatic human melanoma cell line targeted with an argon plasma jet. Plasma treatment was toxic in both cell lines. Modulating the oxygen and nitrogen ambient air composition (100/0, 75/25, 50/50, 25/75, and 0/100) gave similar toxicity and reduced the spheroid growth for all conditions. This was the case for both direct and indirect treatments, with the former showing a treatment time-dependent response while the latter resulted in cytotoxicity with the longest treatment time investigated. Live-cell imaging of in-gel cultured spheroids indicated that plasma treatment did not enhance metastasis, and flow cytometry showed a significant modulation of S100A4 but not in any of the five other metastasis-related markers (β-catenin, E-cadherin, LEF1, SLUG, and ZEB1) investigated. |
first_indexed | 2024-03-10T16:27:09Z |
format | Article |
id | doaj.art-25fa7cbdf7594117bb312a49babec345 |
institution | Directory Open Access Journal |
issn | 2072-6694 |
language | English |
last_indexed | 2024-03-10T16:27:09Z |
publishDate | 2020-09-01 |
publisher | MDPI AG |
record_format | Article |
series | Cancers |
spelling | doaj.art-25fa7cbdf7594117bb312a49babec3452023-11-20T13:08:22ZengMDPI AGCancers2072-66942020-09-01129257010.3390/cancers12092570Plasma Treatment Limits Human Melanoma Spheroid Growth and Metastasis Independent of the Ambient Gas CompositionSybille Hasse0Tita Meder1Eric Freund2Thomas von Woedtke3Sander Bekeschus4ZIK <i>plasmatis</i>, Leibniz Institute for Plasma Science and Technology, Felix-Hausdorff-Str. 2, 17489 Greifswald, GermanyZIK <i>plasmatis</i>, Leibniz Institute for Plasma Science and Technology, Felix-Hausdorff-Str. 2, 17489 Greifswald, GermanyZIK <i>plasmatis</i>, Leibniz Institute for Plasma Science and Technology, Felix-Hausdorff-Str. 2, 17489 Greifswald, GermanyZIK <i>plasmatis</i>, Leibniz Institute for Plasma Science and Technology, Felix-Hausdorff-Str. 2, 17489 Greifswald, GermanyZIK <i>plasmatis</i>, Leibniz Institute for Plasma Science and Technology, Felix-Hausdorff-Str. 2, 17489 Greifswald, GermanyMelanoma skin cancer is still a deadly disease despite recent advances in therapy. Previous studies have suggested medical plasma technology as a promising modality for melanoma treatment. However, the efficacy of plasmas operated under different ambient air conditions and the comparison of direct and indirect plasma treatments are mostly unexplored for this tumor entity. Moreover, exactly how plasma treatment affects melanoma metastasis has still not been explained. Using 3D tumor spheroid models and high-content imaging technology, we addressed these questions by utilizing one metastatic and one non-metastatic human melanoma cell line targeted with an argon plasma jet. Plasma treatment was toxic in both cell lines. Modulating the oxygen and nitrogen ambient air composition (100/0, 75/25, 50/50, 25/75, and 0/100) gave similar toxicity and reduced the spheroid growth for all conditions. This was the case for both direct and indirect treatments, with the former showing a treatment time-dependent response while the latter resulted in cytotoxicity with the longest treatment time investigated. Live-cell imaging of in-gel cultured spheroids indicated that plasma treatment did not enhance metastasis, and flow cytometry showed a significant modulation of S100A4 but not in any of the five other metastasis-related markers (β-catenin, E-cadherin, LEF1, SLUG, and ZEB1) investigated.https://www.mdpi.com/2072-6694/12/9/2570kINPenMNT-1oncologyplasma medicinereactive oxygen speciesROS |
spellingShingle | Sybille Hasse Tita Meder Eric Freund Thomas von Woedtke Sander Bekeschus Plasma Treatment Limits Human Melanoma Spheroid Growth and Metastasis Independent of the Ambient Gas Composition Cancers kINPen MNT-1 oncology plasma medicine reactive oxygen species ROS |
title | Plasma Treatment Limits Human Melanoma Spheroid Growth and Metastasis Independent of the Ambient Gas Composition |
title_full | Plasma Treatment Limits Human Melanoma Spheroid Growth and Metastasis Independent of the Ambient Gas Composition |
title_fullStr | Plasma Treatment Limits Human Melanoma Spheroid Growth and Metastasis Independent of the Ambient Gas Composition |
title_full_unstemmed | Plasma Treatment Limits Human Melanoma Spheroid Growth and Metastasis Independent of the Ambient Gas Composition |
title_short | Plasma Treatment Limits Human Melanoma Spheroid Growth and Metastasis Independent of the Ambient Gas Composition |
title_sort | plasma treatment limits human melanoma spheroid growth and metastasis independent of the ambient gas composition |
topic | kINPen MNT-1 oncology plasma medicine reactive oxygen species ROS |
url | https://www.mdpi.com/2072-6694/12/9/2570 |
work_keys_str_mv | AT sybillehasse plasmatreatmentlimitshumanmelanomaspheroidgrowthandmetastasisindependentoftheambientgascomposition AT titameder plasmatreatmentlimitshumanmelanomaspheroidgrowthandmetastasisindependentoftheambientgascomposition AT ericfreund plasmatreatmentlimitshumanmelanomaspheroidgrowthandmetastasisindependentoftheambientgascomposition AT thomasvonwoedtke plasmatreatmentlimitshumanmelanomaspheroidgrowthandmetastasisindependentoftheambientgascomposition AT sanderbekeschus plasmatreatmentlimitshumanmelanomaspheroidgrowthandmetastasisindependentoftheambientgascomposition |